Latest stories on IART
IART Maintained by UBS -- Price Target Lowered to $14.00
GuruFocus42 · neutralanalyst
Integra LifeSciences price target lowered to $14 from $19 at UBS
The Fly34 · bearishanalyst
Integra LifeSciences: Progress Remains Frustratingly Slow, But Valuation Is Getting Interesting
Seeking Alpha54 · neutralanalyst
Integra LifeSciences price target lowered to $13 from $15 at Truist
The Fly34 · bearishanalyst
Integra LifeSciences price target lowered to $14 from $15 at BMO Capital
The Fly38 · neutralanalyst
Integra LifeSciences price target lowered to $14 from $17 at JPMorgan
The Fly34 · bearishanalyst
Integra LifeSciences price target lowered to $14 from $15 at Citi
The Fly38 · neutralanalyst
Integra LifeSciences price target lowered to $22 from $25 at Citizens
The Fly34 · bearishanalyst
Integra Lifesciences Balances Progress and Near-Term Strain
TipRanks42 · neutralearnings
Integra outlines $1.634B-$1.654B 2026 revenue outlook as Cincinnati disruption extends into Q2 2027
Seeking Alpha38 · neutralearnings
Integra LifeSciences Holdings Corporation (IART) Q3 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Integra: 3 Key Takeaways for Long-Term Investors
The Motley Fool58 · neutralgeneral
Integra LifeSciences Holdings Corporation 2026 Q3 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Integra Life falls as tissue reconstruction woes add to flooding worries in Q3
Seeking Alpha34 · bearishearnings
Integra (IART) Q3 2026 Earnings Call Transcript
The Motley Fool58 · neutralearnings
Integra reaffirms FY26 adjusted EPS view $2.30-$2.40, consensus $2.38
The Fly52 · neutralearnings
Integra LifeSciences lowers FY26 adjusted EPS view to $2.30-$2.40 from $2.40-$2.
The Fly34 · bearishearnings
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) files 8-K
SEC 8-K50 · neutralgeneral
Integra LifeSciences sees Q4 adjusted EPS 61c-71c, consensus 73c
The Fly34 · bearishearnings
Integra LifeSciences Q3 earnings beat estimates, but revenue falls short
Seeking Alpha54 · neutralearnings
Integra LifeSciences reports Q3 adjusted EPS 59c, consensus 56c
The Fly63 · neutralearnings
Integra LifeSciences Reports Third Quarter 2026 Financial Results
Business Insider50 · neutralearnings
Integra LifeSciences Reports Third Quarter 2026 Financial Results
GlobeNewswire50 · neutralearnings